BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25229646)

  • 1. Emodin suppresses maintenance of stemness by augmenting proteosomal degradation of epidermal growth factor receptor/epidermal growth factor receptor variant III in glioma stem cells.
    Kim J; Lee JS; Jung J; Lim I; Lee JY; Park MJ
    Stem Cells Dev; 2015 Feb; 24(3):284-95. PubMed ID: 25229646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saccharina japonica Extract Suppresses Stemness of Glioma Stem Cells by Degrading Epidermal Growth Factor Receptor/Epidermal Growth Factor Receptor Variant III.
    Kim SY; Kim JY; Shin WS; Lee SJ; Chi SG; Lee JY; Park MJ
    J Med Food; 2018 May; 21(5):496-505. PubMed ID: 29648968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PARK7 maintains the stemness of glioblastoma stem cells by stabilizing epidermal growth factor receptor variant III.
    Kim JY; Kim HJ; Jung CW; Choi BI; Lee DH; Park MJ
    Oncogene; 2021 Jan; 40(3):508-521. PubMed ID: 33188296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of Her2/neu binding to Hsp90 by emodin azide methyl anthraquinone derivative induces proteasomal degradation of Her2/neu.
    Yan YY; Zheng LS; Zhang X; Chen LK; Singh S; Wang F; Zhang JY; Liang YJ; Dai CL; Gu LQ; Zeng MS; Talele TT; Chen ZS; Fu LW
    Mol Pharm; 2011 Oct; 8(5):1687-97. PubMed ID: 21812426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs).
    Li X; Tao Z; Wang H; Deng Z; Zhou Y; Du Z
    Exp Cell Res; 2020 Nov; 396(1):112261. PubMed ID: 32896567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emodin Suppresses the Migration and Invasion of Melanoma Cells.
    Liu C; Chen L; Wang W; Qin D; Jia C; Yuan M; Wang H; Guo Y; Zhu J; Zhou Y; Zhao H; Liu T
    Biol Pharm Bull; 2021 Jun; 44(6):771-779. PubMed ID: 33731543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
    Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
    Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
    Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
    Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer.
    Shrimali D; Shanmugam MK; Kumar AP; Zhang J; Tan BK; Ahn KS; Sethi G
    Cancer Lett; 2013 Dec; 341(2):139-49. PubMed ID: 23962559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: targeting PI3K-AKT-mTOR signaling, HSP90 and histone deacetylases.
    Choi EJ; Cho BJ; Lee DJ; Hwang YH; Chun SH; Kim HH; Kim IA
    BMC Cancer; 2014 Jan; 14():17. PubMed ID: 24418474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation.
    Ouyang WC; Liao YW; Chen PN; Lu KH; Yu CC; Hsieh PL
    Cancer Chemother Pharmacol; 2017 Aug; 80(2):411-419. PubMed ID: 28685346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ANO1 regulates the maintenance of stemness in glioblastoma stem cells by stabilizing EGFRvIII.
    Kim HJ; Kim JY; Jung CW; Lee YS; An JY; Kim EH; Kim KH; Lee SP; Park JY; Park MJ
    Oncogene; 2021 Feb; 40(8):1490-1502. PubMed ID: 33452454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gefitinib radiosensitizes stem-like glioma cells: inhibition of epidermal growth factor receptor-Akt-DNA-PK signaling, accompanied by inhibition of DNA double-strand break repair.
    Kang KB; Zhu C; Wong YL; Gao Q; Ty A; Wong MC
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e43-52. PubMed ID: 22516386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor.
    Ciaglia E; Abate M; Laezza C; Pisanti S; Vitale M; Seneca V; Torelli G; Franceschelli S; Catapano G; Gazzerro P; Bifulco M
    Int J Cancer; 2017 Feb; 140(4):959-972. PubMed ID: 27813087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emodin as an effective agent in targeting cancer stem-like side population cells of gallbladder carcinoma.
    Li XX; Dong Y; Wang W; Wang HL; Chen YY; Shi GY; Yi J; Wang J
    Stem Cells Dev; 2013 Feb; 22(4):554-66. PubMed ID: 22974371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol promotes proteasome-dependent degradation of Nanog via p53 activation and induces differentiation of glioma stem cells.
    Sato A; Okada M; Shibuya K; Watanabe E; Seino S; Suzuki K; Narita Y; Shibui S; Kayama T; Kitanaka C
    Stem Cell Res; 2013 Jul; 11(1):601-10. PubMed ID: 23651583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emodin attenuates radioresistance induced by hypoxia in HepG2 cells via the enhancement of PARP1 cleavage and inhibition of JMJD2B.
    Hwang SY; Heo K; Kim JS; Im JW; Lee SM; Cho M; Kang DH; Heo J; Lee JW; Choi CW; Yang K
    Oncol Rep; 2015 Apr; 33(4):1691-8. PubMed ID: 25607726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emodin potentiates the antiproliferative effect of interferon α/β by activation of JAK/STAT pathway signaling through inhibition of the 26S proteasome.
    He Y; Huang J; Wang P; Shen X; Li S; Yang L; Liu W; Suksamrarn A; Zhang G; Wang F
    Oncotarget; 2016 Jan; 7(4):4664-79. PubMed ID: 26683360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.
    Yoo YD; Lee DH; Cha-Molstad H; Kim H; Mun SR; Ji C; Park SH; Sung KS; Choi SA; Hwang J; Park DM; Kim SK; Park KJ; Kang SH; Oh SC; Ciechanover A; Lee YJ; Kim BY; Kwon YT
    EMBO Rep; 2017 Jan; 18(1):150-168. PubMed ID: 27993939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy.
    Gong X; Schwartz PH; Linskey ME; Bota DA
    Neurology; 2011 Mar; 76(13):1126-34. PubMed ID: 21346220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.